The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.


Updates from The Motley Fool

Latest updates on SPDR S and P Pharmaceuticals from Fool.com.


Stock Performance

XPH vs. S&P 500 | 2 Year Performance
View Interactive XPH Charts
Sponsored by

Key Data Points

Primary metrics and data points about SPDR S and P Pharmaceuticals.
Current Price: $45.08
Prev Close: $45.04
Open: $45.17
Bid: $45.06
Ask: $45.10
Day's Range: $44.60 - $45.34
52wk Range: $37.31 - $59.73
Volume: 48,665
Avg Vol 138,504
Market Cap: $581.54M
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.29 (0.5%)

Company Rating

What our community thinks about SPDR S and P Pharmaceuticals.
CAPS Rating 3 out of 5
 
29 Outperform
6 Underperform
CAPS All Stars
 
5 Outperform
2 Underperform

How do you think SPDR S and P Pharmaceuticals will perform against the market?



You pick for SPDR S and P Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for SPDR S and P Pharmaceuticals.

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index.

  • Exchange: NYSEMKT
  • Sector: Sector Equity
  • Industry: Health/Biotechnology Funds